))
Additional Advances in Triple-Negative Breast Cancer Research and Trials: Sara M. Tolaney, MD, MPH
Manage episode 420015994 series 3456244
内容由i3 Health and I3 Health提供。所有播客内容（包括剧集、图形和播客描述）均由 i3 Health and I3 Health 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Last year, Dr. Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, served as co-chair of i3 Health’s webinar and online activity, Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC). With numerous advances in TNBC research occurring since then, Dr. Tolaney sat down with Oncology Data Advisor to share additional updates from clinical trials and a preview into the future of treatment with emerging therapies for TNBC. To complete the CME/NCPD activity, follow this link: https://bit.ly/3KhoDVG
…
continue reading
38集单集
分享
